Skip to main content

and
  1. Article

    Open Access

    Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer

    The Dutch Pancreatic Cancer Group initiated the national, multicentre, controlled PREOPANC trial, randomising between preoperative radiochemotherapy and direct explorative laparotomy for patients with (borderl...

    Eva Versteijne, Eelco Lens, Astrid van der Horst in Strahlentherapie und Onkologie (2017)

  2. No Access

    Chapter

    Pancreatic Resection After Neoadjuvant Treatment

    Pancreatic cancer has a very poor prognosis, with the projection to be the second leading cancer-related death in 2020 [1]. Pancreatic cancer can be divided in three stages: resectable (15%), locally advanced ...

    Mustafa Suker, Casper H. J. van Eijck in Minimally Invasive Surgery for Upper Abdom… (2017)

  3. Article

    Open Access

    Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial

    Pancreatic cancer is the fourth largest cause of cancer death in the United States and Europe with over 100,000 deaths per year in Europe alone. The overall 5-year survival ranges from 2–7 % and has hardly imp...

    Eva Versteijne, Casper H. J. van Eijck, Cornelis J. A. Punt, Mustafa Suker in Trials (2016)